e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Published

Glutamate toxicity in Neurological diseases

Published in November 2017 Issue 11 (Vol. 5, Issue 11, 2017)

Glutamate toxicity in Neurological diseases - Issue cover

Abstract

ABSTRACTGlutamate is a neuro transmitter and is responsible for communication between cells. Under pathophysiological conditions its concentration is increased within the brain and results in glutamate toxicity. Increased glutamate in the brain can elicit damage and ultimately neuronal death. Glutamate toxicity is associated with various neurodegenerative diseases like Parkinson's disease, Alzheimer's disease, stroke, amyotrophic lateral sclerosis (ALS), multiple sclerosis and head trauma. However, it should be noted here that the molecular mechanism behind the glutamate toxicity is not fully understood and is quiet complex. Reducing glutamate toxicity is considered to be the most essential strategy to combat various neurological disorders. In this review, we have summarized previous studies to understand the cellular effects associated with the glutamate toxicity Keywords: Glutamate toxicity, Neurological disorders, Alzheimer's disease, amyotrophic lateral sclerosis Glutamate transporter-1

Authors (3)

Ajaz Ahmad Waza

Centre

View all publications →

Shabir Ahmad Bhat

Centre

View all publications →

Zeenat Hamid

Department of Biotechnology, U...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPHR511001

AJPHR-51-000001

2017-11-01

Article Impact

Views:3,255
Downloads:1,782

How to Cite

Ahmad, A., & Ahmad, S. & Zeenat Hamid (2017). Glutamate toxicity in Neurological diseases. American Journal of Pharmacy and Health Research, 5(11), xx-xx. https://ajphr.com/articles/AJPHR511001

Article Actions